Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00655915 · ClinicalTrials.gov registry record
Corticosteroid Injection as a Predictor of Outcome in Carpal Tunnel Release
A clinical trial, sponsored by Vanderbilt University.
- Terminated
- Registry status
- 200
- Enrollment target
NCT00655915: Clinical Trial study, sponsored by Vanderbilt University.
NCT00655915 is a clinical trial that was terminated before completion, run by Vanderbilt University. The registered enrollment target is 200 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00655915 was terminated before completion, sponsored by Vanderbilt University.
- TERMINATED
- Registry status
- 200 participants
- Enrollment target
Study Summary
This study will investigate whether symptomatic improvement following carpal tunnel corticosteroid injection can be correlated to symptomatic improvement following carpal tunnel release and therefore serve as a prognostic indicator. Clinical question: Does response to corticosteroid injection in CTS predict outcomes of surgical treatment? Secondary Questions: 1. Can we confirm previous retrospectively collected data that a certain percentage of conservatively managed patients with steroid injection will avoid surgery, and that patients who undergo surgery will have better outcomes than those who do not. 2. Are there differences between worker's compensation and non-worker's compensation patients with regard to the primary clinical question? 3. What are Carpal Tunnel Release outcomes for the subset of patients with negative electrophysiologic studies? 4. What are the outcomes of patients who undergo carpal tunnel release vs. those who choose not to undergo carpal tunnel release? A prospective cohort design study is the appropriate study design in order to measure the association between a predictor (response to injection) and outcome (response to surgery).
Interventions
- OTHER Corticosteroid Injection- 1ml of Betamethasone and 1 ml of 1% Lidocaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2007-12 |
| Est. Completion | 2011-03 |
Why NCT00655915 stopped before completion
NCT00655915 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Corticosteroid Injection- 1ml of Betamethasone and 1 ml of 1% Lidocaine is the first listed.
NCT00655915 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00655915 about?
NCT00655915 is a clinical study titled "Corticosteroid Injection as a Predictor of Outcome in Carpal Tunnel Release". This study will investigate whether symptomatic improvement following carpal tunnel corticosteroid injection can be correlated to symptomatic improvement following carpal tunnel release and therefore serve as a prognostic indicator. Clinical question: Does response to corticosteroid injection in CT...
What is the current status of trial NCT00655915?
This trial is currently terminated. The enrollment target is 200 participants. The study started on 2007-12. Estimated completion is 2011-03.
What interventions are being tested in trial NCT00655915?
The interventions under investigation include: Corticosteroid Injection- 1ml of Betamethasone and 1 ml of 1% Lidocaine (OTHER).
Who is sponsoring clinical trial NCT00655915?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia